Big Data

There are many challenges facing the biotech industry today, such as quality assurance, counterfeiting and research intransparency. GENEXI is determined to deliver a holistic solution in the form of a transparent and comprehensive blockchain-based ecosystem on to the market. Within GENEXI Ecosystem biotech start-ups and projects will be able to find financial and advisory support to establish and scale-up their production. Upon entering the GENEXI Platform, distributors will be able to provide their services and build networks with vendors, while regular customers will gain an access to complete immutable data about the products. At the same time, third-party service providers will be able to present their support to other participants of the community. GENEXI plans to integrate its unique blockchain solution throughout the entire supply chain management process in order to fight drug counterfeit, fraud and quality manipulation and ensure full transparency at every level.

TOKEN SALE 2018-06-01 - 2018-08-31

Ticker: GEN
Platform: Ethereum
ICO Token price: 1 GEN = 0.01 USD
Fundraising Goal: 70,000,000 USD
Total Tokens: 12,000,000,000
Available for Token Sale: 8,400,000,000
Whitelist/KYC: No
Сan't Participate: USA
Bonuses: Pre-Sale Round, 01.05 - 31.05 20% Token Sale Round 1, 01.06 – 14.06 17% Token Sale Round 2, 15.06 – 05.07 9% Token Sale Round 3, 06.07 – 26.07 5% Token Sale Round 4, 27.07 – 31.08 2%
Accepts the following: BTC, ETH, BCH, XMR, DSH, LTC, B2B, USDT


Country: Singapore
Role of Token: Accelerating Biotech Breakthroughs
Number of Team Members: 32
Unsold Tokens: Burned




Share the ICO Ratings